Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Sun Pharmaceutical Industries Ltd.
₹1,862.30
₹1858.00
₹1887.00
₹1548.00
₹1916.60
Markets Today
Historical Performance
As of 26-06-2026 04:20, Sun Pharmaceutical Industries Ltd. share price today is ₹0, with a change of ₹-1874.40 (-100.00%) from the previous close of ₹1874.4. The stock opened at ₹1870 and traded between ₹1858 and ₹1887, with a total traded volume of 1816438 shares. The company has a market capitalization of ₹446948.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1916.6 and ₹1548, respectively.
Sun Pharmaceutical Industries Ltd. valuation metrics include a P/E ratio of 38.9, EPS of ₹47.8, and book value of ₹5.30. Profitability indicators show ROE of 13.73% along with a dividend yield of 0.9%. Sun Pharmaceutical Industries Ltd. has reported revenue of ₹58462.04 Cr and net profit of ₹11479.42 Cr.
Sun Pharmaceutical Industries Ltd. technical indicators include Day RSI at 66.93, Day MFI at 78.06, Day ADX at 17.39. Additional indicators include Commodity Channel Index (CCI) at 166.7 and Williams %R at -20.54. Momentum indicators show Day MACD at 13.13, Day MACD Signal Line at 5.45, DayATR at 30.5. Rate of Change indicators for Sun Pharmaceutical Industries Ltd. include ROC125 at 7.36 and ROC21 at 1.84.
Exponential moving averages include EMA5 at ₹1855.5, EMA10 at ₹1838.5, EMA12 at ₹1834.6, EMA20 at ₹1826, EMA26 at ₹1821.5, EMA50 at ₹1804.6, EMA100 at ₹1778.2, EMA200 at ₹1749.4. Simple moving averages include SMA5 at ₹1853.7, SMA10 at ₹1829.7, SMA20 at ₹1811.6, SMA30 at ₹1829.5, SMA50 at ₹1797.4, SMA100 at ₹1763.9, SMA150 at ₹1759.1, SMA200 at ₹1731.9.
Support levels for Sun Pharmaceutical are placed at First Support ₹1865.50, Second Support ₹1856.60, Third Support ₹1848.30. Resistance levels are seen at First Resistance ₹1882.70, Second Resistance ₹1891.00, Third Resistance ₹1899.90. Sun Pharmaceutical Industries Ltd. shareholding pattern shows promoter holding at 54.48%, FII holding at 15.94%, DII holding at 0%, public holding at 8.48%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 4,923.88 | 5,687.77 | 4,548.11 | 5,601.96 | 7,185.74 |
| Operating Expense | 3,594.91 | 3,929.17 | 3,364.52 | 3,710.81 | 4,196.28 |
| Operating Profit | 1,328.97 | 1,758.60 | 1,183.59 | 1,891.15 | 2,989.46 |
| Depreciation | 325.97 | 338.53 | 336.30 | 299.03 | 291.96 |
| Interest | 216.92 | 244.17 | 248.33 | 223.29 | 217.42 |
| Tax | 215.02 | 482.06 | 107.53 | 431.35 | 611.62 |
| Net Profit | 608.70 | 705.44 | 564.22 | 753.53 | 2,000.46 |
Research Type
Equity , Long Term
Buy Range
₹1,706 - ₹0
Target Price
₹2,000
Stop Loss
-
Target Date
23 Aug 26
Potential Returns
17.23 %
₹1862.30
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 54.5 | 54.5 | 54.5 | 54.5 | 54.5 | 54.5 |
| FII | 18 | 18 | 17.3 | 16.6 | 16.1 | 15.9 |
| DII | 18.6 | 18.6 | 19.5 | 20.2 | 20.9 | 21.1 |
| Public | 8.9 | 8.9 | 8.5 | 8.7 | 8.6 | 8.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 10.08 L | 14.38 L | 70.10% |
| Week | 14.64 L | 22.47 L | 65.15% |
| 1 Month | 18.25 L | 27.49 L | 66.39% |
| 6 Month | 21.54 L | 33.6 L | 64.09% |
Benjamin Graham Value Screen
Turnaround Potential (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Stocks with Consistent Share Price Growth (subscription)
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 07 Jul, 2026 | 5 | FINAL | 07 Jul, 2026 | Equity Share |
| 05 Feb, 2026 | 11 | INTERIM | 05 Feb, 2026 | Equity Share |
| 07 Jul, 2025 | 5.5 | FINAL | 07 Jul, 2025 | Equity Share |
| 06 Feb, 2025 | 10.5 | INTERIM | 06 Feb, 2025 | Equity Share |
| 12 Jul, 2024 | 5 | FINAL | 12 Jul, 2024 | Equity Share |
| 09 Feb, 2024 | 8.5 | INTERIM | 09 Feb, 2024 | Equity Share |
| 28 Jul, 2023 | 4 | FINAL | 28 Jul, 2023 | Equity Share |
| 08 Feb, 2023 | 7.5 | INTERIM | 08 Feb, 2023 | Equity Share |
| 19 Aug, 2022 | 3 | FINAL | 22 Aug, 2022 | Equity Share |
| 09 Feb, 2022 | 7 | INTERIM | 10 Feb, 2022 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,410.90 | ₹761.40 | ₹1,218.10 | ₹1,880 | ₹2,461 | ₹167.45 |
| % Change | 1.34% | -1.00% | 1.09% | 2.17% | -0.89% | -2.89% |
| Revenue TTM (₹ Cr) | ₹1,753.96 | ₹2,124.33 | ₹2,192.49 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹246.74 | ₹591.79 | ₹348.91 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 95.00 | 72.50 | 74.30 | 38.60 | 53.20 | -68.50 |
| 1 Year Return | 192.08 | 33.63 | 63.52 | 39.38 | 6.71 | -16.14 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3300.00
+0.96%
Gland Pharma Ltd.
₹ 2315.00
-0.48%
Eris Lifesciences Ltd.
₹ 1459.70
-0.46%
Laurus Labs Ltd.
₹ 1452.40
-0.12%
Alkem Laboratories Ltd.
₹ 5425.00
-0.06%
Biocon Ltd.
₹ 416.00
-1.11%
Divi's Laboratories Ltd.
₹ 6700.50
-0.78%
Ajanta Pharma Ltd.
₹ 3205.00
-1.56%
Zydus Lifesciences Ltd.
₹ 1100.90
+0.15%
Glenmark Pharmaceuticals Ltd.
₹ 2154.30
-1.21%
Wockhardt Ltd.
₹ 1962.00
-0.32%
Aurobindo Pharma Ltd.
₹ 1555.20
+1.61%
Neuland Laboratories Ltd.
₹ 17968.00
-0.58%
Ipca Laboratories Ltd.
₹ 1619.90
-0.08%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2238.70
+0.26%
AstraZeneca Pharma India Ltd.
₹ 8433.00
-0.11%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2366.00
-0.03%
Pfizer Ltd.
₹ 4460.00
-1.05%
Abbott India Ltd.
₹ 25600.00
+0.02%
Torrent Pharmaceuticals Ltd.
₹ 4519.80
+0.34%
Lupin Ltd.
₹ 2348.50
-0.81%
Dr. Reddy's Laboratories Ltd.
₹ 1349.50
+1.59%
Cipla Ltd.
₹ 1439.20
+0.09%
By signing up I certify terms, conditions & privacy policy